Scholar Rock targets 2026 apitegromab BLA resubmission and launch

Go back to Scholar Rock targets 2026 apitegromab BLA resubmission and launch
(NASDAQ: SRRK) Delayed: 55.24 -0.43 (0.77%)
Previous Close $55.67    52 Week High
Open $55.67    52 Week Low
Day High $56.94    P/E N/A 
Day Low $55.24    EPS
Volume 260,324